Within two months, a well-known domestic pharmaceutical companies to cooperate with three commercial giants

Recently, North China Pharmaceuticals announced the signing of the Strategic Cooperation Framework Agreement with the China Pharmaceutical-Chongqing Pharmaceutical Business Complex.
agreement, the two sides will work together to deepen strategic cooperation, promote multi-faceted docking of sales business, and promote mutual benefit and win-win cooperation between enterprises.
It is understood that The China Pharmaceutical-Chongqing Pharmaceutical Business Complex was founded on December 3rd, with equity as the link between China Pharma and Chongqing Pharmaceuticals, to carry out multi-faceted and multi-level cooperation in market development, product resources, channel resources, etc., to achieve greater scale and synergies.
, the chinese pharmaceutical-Chongqing pharmaceutical business complex has the advantage of channels and distribution, while North China Pharmaceuticals belongs to the pharmaceutical manufacturing industry.
cooperation, the two sides will work together to deepen strategic cooperation, or will enable the future of North China Pharmaceutical varieties through the above-mentioned joint rapid promotion.
fact, it is worth noting that this cooperation is the third time in two months that North China Pharmaceuticals has conducted strategic cooperation with pharmaceutical commercial enterprises.
July 17, the signing ceremony of the Letter of Intent for Strategic Cooperation between North China Pharmaceuticals and China National Pharmaceutical Holdings was held in Huamin.
company leaders Zhou Xiaobing and Wang Lichen, Wang Yang, deputy general manager of the National Pharmaceutical Holdings Center, and relevant personnel from both sides attended the signing ceremony.
signing ceremony, China Pharmaceutical Holdings and North China Pharmaceuticals related business leaders respectively carried out the enterprise introduction and development concept sharing, and on the next step of communication.
, the two sides signed a Letter of Intent for Strategic Cooperation.
July 29, North China Pharmaceuticals and Shanghai Pharmaceutical Holdings signed the Strategic Partnership Framework Agreement.
the two sides will cooperate in product procurement, bidding, distribution and other aspects to help the two sides achieve mutual benefit and common development.
signing ceremony, Shanghai Pharmaceutical Holdings and North China Pharmaceuticals related business leaders respectively on the development of their respective enterprises, industrial layout, marketing structure, social responsibility and cooperation prospects for the introduction and communication.
both sides said that they will fully cooperate and help the two sides to cooperate from the point and face, from the domestic to the international, complementary advantages, bigger and stronger.
from the above point of view, within two months, North China Pharmaceuticals has been working with three pharmaceutical commercial companies in a row, and the partners have occupied the resources and volume of the head in the pharmaceutical circulation industry.
To some extent, this will greatly improve their channel coverage and terminal control, through the three companies covering the country's distribution terminal network, the rapid promotion of products to the country, to achieve volume, the future results will be directly reflected in its performance.
In fact, in recent years, under the influence of policies such as "4 plus 7" volume procurement, medical insurance control fees, two-vote system, the sales volume and price of many enterprises have fallen sharply, sales and profit pressure, relying on the past "academic marketing" approach has obviously been difficult to obtain higher profits, many pharmaceutical companies are using a variety of ways to expand sales channels.
, in addition to North China Pharmaceuticals, industrial enterprises and commercial enterprises in the industry is not uncommon.
such as China Resources Pharmaceuticals and Dongsan Pharmaceuticals signed a strategic cooperation framework agreement in January this year, intended to enhance the core product "Covey" estravy phosphate supply.
Sun Medicine will use China Resources Pharmaceuticals commercial distribution network and drug reserve capacity to strengthen the end-of-product coverage.
, this kind of cooperation between industrial enterprises and commercial enterprises is essentially the cooperation between manufacturers and channels.
industrial enterprises to provide varieties, commercial enterprises to promote products, after all, the advantages of commercial enterprises in the channel, which has a nationwide coverage of the terminal network, but also have matching transport vehicles and cold chain vehicles.
The industry believes that, according to this trend, in the future, with the increasing concentration of the industry, more and more industrial enterprises will choose to establish strategic cooperation with the four major pharmaceutical commercial companies, pharmaceutical companies focus on research and development and production, commercial enterprises are responsible for promotion and marketing, give full play to the advantages of both sides.